Company Filing History:
Years Active: 2014
Title: **Innovator Stephen H. Colbert: Pioneering Engineered Biological Nerve Grafts**
Introduction
Stephen H. Colbert, based in Columbia, MO, is an accomplished inventor recognized for his significant contribution to the field of biomedical engineering. His innovative work focuses on creating engineered biological nerve grafts, which have profound implications for nerve repair and regeneration in living organisms. With one patent to his name, Colbert is at the forefront of advancements in nerve injury treatments.
Latest Patents
Colbert's sole patent is titled "Engineered Biological Nerve Graft, Fabrication and Application Thereof." This patent describes an engineered three-dimensional structure composed of living cells cohered together. The graft includes Schwann cells, integral to nerve healing, along with at least one other type of cell, such as bone marrow stem cells known for their anti-inflammatory properties. This innovative structure facilitates restorative axon growth when implanted between severed nerve stubs, thus enhancing recovery outcomes.
Career Highlights
Colbert works with The Curators of the University of Missouri, where his research focuses on advanced regenerative medicine techniques. His pioneering approaches are critical in developing methods for nerve restoration, showcasing his commitment to improving clinical outcomes for nerve injuries.
Collaborations
Throughout his career, Colbert has collaborated with prominent researchers in the field, including Gabor Forgacs and Bradley A. Hubbard. These collaborations have fostered a supportive environment for innovation, leading to the creation of groundbreaking technologies in the realm of nerve regeneration.
Conclusion
Stephen H. Colbert's contributions to the development of engineered biological nerve grafts not only advance scientific knowledge but also hold the potential to transform the lives of individuals affected by nerve injuries. His collaboration with esteemed colleagues and his commitment to research at The Curators of the University of Missouri solidify his position as a key innovator in the field of biomedical engineering.